Recovery peptides studied for muscle and soft-tissue repair, performance and wound healing.
GH/IGF-1 signalling promotes protein synthesis, lean-tissue growth and repair — established in deficiency and wasting states.
Accelerates muscle healing and revascularisation after crush/transection injury in rodents.
Speeds cell migration and angiogenesis in muscle and soft-tissue repair in animal models.
Approved to improve muscle strength in Barth syndrome and studied in mitochondrial myopathy, where fatigue is bioenergetic in origin.
Showed synergistic metabolic gains when combined with exercise training in animals.
Raising GH/IGF-1 modestly increases lean body mass.
Elevated GH/IGF-1 is theorised to aid recovery and lean mass; controlled human trials are lacking.
With resistance training, shows modest lean-mass/strength gains, especially in older adults.
Preliminary data on arterial stiffness and physical performance in older adults.
⚠️ Educational research information only — not medical advice. Many peptides are research-use-only and not approved treatments. Always consult a qualified professional.